Business

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identific...

articleHealwell Ai Inc. Class AFebruary 19, 20264/company/healwell-ai-inc/news/well-health-and-healwell-ai-launch-welltrust-to-empower-patients-and-accelerate-ai-powered-ethical-patient-identification-for-clinical-research-1
WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

About this update from Healwell Ai Inc. Class A

[{"type":"text","content":"WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n \n\n\n\n\n WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization across WELL-operated clinics.\n \n\n WELLTRUST provides patients with clear, flexible, and revocable control over consent, while enabling researchers and clinicians to identify appropriate patients in an ethical, privacy-first way.\n \n\n The first commercial application combines WELL’s expansive clinical footprint with HEALWELL’s DARWEN™ AI platform to identify and engage high-fit patients with chronic, rare, and complex conditions for clinical trials, improving recruitment at scale while preserving privacy.\n \n\n\n\n\n WELL Health Technologies Corp. (TSX: WELL; OTCQX: WHTCF)\n \n\n (the\n \n “Company”\n \n or\n \n “WELL”\n \n ),\n \n\n a technology-enabled healthcare company operating outpatient clinics that leverage scalable digital health solutions, and HEALWELL AI Inc. (“\n \n HEALWELL\n \n ”) (TSX: AIDX) (OTCQX: HWAIF), a healthcare artificial intelligence company focused on preventative care, are jointly pleased to announce the launch of the first phase of\n \n WELLTRUST™\n \n , a platform enabling secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada.\n \n\n WELLTRUST accelerates clinical research recruitment by enabling patients interested in clinical trials and research to consent to future outreach. By combining WELL’s extensive clinical footprint with HEALWELL’s advanced AI capabilities, WELLTRUST provides a scalable, privacy-preserving infrastructure that accelerates research by developing a database of individuals who are interested in participating in such research. Patients who are not interested in participating in WELLTRUST can safely and securely decline participation and continue receiving care at WELL clinics as they had before.\n \n\n Dr. Alexander Dobranowski, President of HEALWELL AI commented, “WELLTRUST embodies our commitment ...

More updates from Healwell Ai Inc. Class A